Inovatyvių medicinos technologijų ir biofarmacijos asociacija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
37,559 |
37,559 |
0 |
- |
- |
- |
- |
-127,348 |
219,386 |
36,493 |
55,545 |
2022 |
---|
54,842 |
- |
0 |
- |
- |
- |
- |
-134,102 |
220,930 |
12,166 |
74,662 |
2023 |
---|
51,031 |
- |
0 |
- |
- |
- |
- |
-127,587 |
226,762 |
3 |
99,172 |
Register and
explore Okredo data2023 |
---|
51,031 |
- |
0 |
- |
- |
- |
- |
-127,587 |
226,762 |
3 |
99,172 |
Register and
explore Okredo data2023
Turnover (€)
51,031 €-7 % *
Sales per employee (€)
-Profit before tax (€)
0 €- *
Net Profit (€)
-Profit per employee (€)
-Total profitability (%)
-Net profitability (%)
-Equity (€)
-127,587 €5 % *
Amounts Payable And Liabilities (€)
226,762 €3 % *
Non-current Assets (€)
3 €-100 % *
CurrentAssets (€)
99,172 €33 % *